Ilic, I.; Potthoff, A.-L.; Borger, V.; Heimann, M.; Paech, D.; Giordano, F.A.; Schmeel, L.C.; Radbruch, A.; Schuss, P.; Schäfer, N.;
et al. Bone Mineral Density as an Individual Prognostic Biomarker in Patients with Surgically-Treated Brain Metastasis from Lung Cancer (NSCLC). Cancers 2022, 14, 4633.
https://doi.org/10.3390/cancers14194633
AMA Style
Ilic I, Potthoff A-L, Borger V, Heimann M, Paech D, Giordano FA, Schmeel LC, Radbruch A, Schuss P, Schäfer N,
et al. Bone Mineral Density as an Individual Prognostic Biomarker in Patients with Surgically-Treated Brain Metastasis from Lung Cancer (NSCLC). Cancers. 2022; 14(19):4633.
https://doi.org/10.3390/cancers14194633
Chicago/Turabian Style
Ilic, Inja, Anna-Laura Potthoff, Valeri Borger, Muriel Heimann, Daniel Paech, Frank Anton Giordano, Leonard Christopher Schmeel, Alexander Radbruch, Patrick Schuss, Niklas Schäfer,
and et al. 2022. "Bone Mineral Density as an Individual Prognostic Biomarker in Patients with Surgically-Treated Brain Metastasis from Lung Cancer (NSCLC)" Cancers 14, no. 19: 4633.
https://doi.org/10.3390/cancers14194633
APA Style
Ilic, I., Potthoff, A.-L., Borger, V., Heimann, M., Paech, D., Giordano, F. A., Schmeel, L. C., Radbruch, A., Schuss, P., Schäfer, N., Herrlinger, U., Vatter, H., Lakghomi, A., & Schneider, M.
(2022). Bone Mineral Density as an Individual Prognostic Biomarker in Patients with Surgically-Treated Brain Metastasis from Lung Cancer (NSCLC). Cancers, 14(19), 4633.
https://doi.org/10.3390/cancers14194633
